First drug to demonstrate therapeutic effect in a type of autism identified
May 21st, 2010 - 2:53 pm ICT by ANIWashington, May 20 (ANI): American researchers have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS).
Previous research has shown that a gene mutation in the brain called SHANK3 can cause absent or severely delayed language abilities, intellectual disability, and autism.
Researchers at Mount Sinai School of Medicine developed mice with a mutant SHANK3 gene and observed a lapse in communication between nerve cells in the brain, which can lead to learning problems. This communication breakdown indicated that the nerve cells were not maturing properly.
The scientists then injected the mice with a derivative of a compound called insulin-like growth factor-1 (IGF1), which is FDA-approved to treat growth failure in children.
After two weeks of treatment, nerve cell communication was normal and adaptation of nerve cells to stimulation, a key part of learning and memory, was restored.
Joseph Buxbaum, Director of the Seaver Autism Center for Research and Treatment at Mount Sinai School of Medicine, said: “The result of IGF1 treatment of these mice is an exciting development on the road to ultimate therapies for individuals with PMS.
“If these data are further verified in additional preclinical studies, individuals with a SHANK3 mutation may benefit from treatments with compounds like this one.” (ANI)
- How a gene mutation leads to autism - Dec 17, 2010
- Potential therapeutic target for improving long-term memory identified - Jan 27, 2011
- Scientists successful in creating autism like traits in mice - Mar 22, 2011
- 5 more genes behind Alzheimer's disease risk identified - Apr 04, 2011
- 'Gluttony gene' forces you to gobble non-stop - Mar 19, 2012
- Mechanism behind cleft palate development found - Sep 15, 2010
- Growth defects in patients with cystic fibrosis 'may start before birth' - Nov 10, 2010
- Novel gene variants behind autism and mental retardation discovered - May 26, 2010
- Scientists shed new light on proteins in brain fluids - Mar 12, 2011
- Scientists find protein that boosts memory, prevents forgetfulness - Feb 03, 2011
- Brain chemical boosts memory, could treat Alzheimer's - Jan 27, 2011
- New compound destroys deadly flu virus - Sep 26, 2011
- How mutations in a gene cause Parkinson's disease - Mar 26, 2011
- Why autism is more prevalent in boys - Sep 16, 2010
- Gene linked to severity of autism's social dysfunction identified - Apr 07, 2011
Tags: american researchers, autism center, buxbaum, communication breakdown, gene mutation, growth factor 1, growth failure, insulin like growth factor, intellectual disability, language abilities, learning and memory, mcdermid, mount sinai school, mount sinai school of medicine, mouse model, nerve cell communication, nerve cells, preclinical studies, school of medicine, therapeutic effect